A practical dead time correction method in planar activity quantification for dosimetry during radionuclide therapy

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 6, 2009, Pages 658-670

  Chiesa, C ^a   Negri, A ^b   Albertini, C ^c   Azzeroni, R ^b   Setti, E ^a   Mainardi, L ^c   Aliberti, G ^a   Seregni, E ^a   Bombardieri, E ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c POLITECNICO DI MILANO   (Italy)

Author keywords

Gamma cameras; Radionuclide imaging; Radiopharmaceuticals

Indexed keywords

IODINE 131; RADIOISOTOPE; TECHNETIUM 99M;

ACCURACY; ANALYTICAL ERROR; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEAD TIME; DOSE CALCULATION; DOSIMETRY; ENERGY; HUMAN; IMAGE QUALITY; NUCLEAR MEDICINE; RADIOACTIVITY; RADIOISOTOPE THERAPY; SCINTILLATION CAMERA; VALIDATION STUDY; WHOLE BODY IMAGING;

AREA UNDER CURVE; CALIBRATION; GAMMA CAMERAS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MODELS, STATISTICAL; PHANTOMS, IMAGING; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; TECHNETIUM; TIME FACTORS; WHOLE BODY IMAGING;

EID: 77949838304     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wiseman GA, Kornmehl E, Leigh B, Erwin WD, Podoloff D, Spies S et al. Radiation dosimetry results and safety correlations from 90Y ibritumomab iuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials. J Nucl Med 2003;44:465-74.
2. Wahl RL, Zasadny KR, MacFarlane D, Francis IR, Ross CW, Estes J et al. Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience. J Nucl Med 1998;39(Suppl):21S-7S.
3. Brans B, Bodei L, Giammarile F, Linden O, Lustre M, Oyen WJG et al. Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging 2007;34:772-86.
4. Flux G, Bardies M, Chiesa C, Monsieurs M, Savolainen Sauli, Strand SE et al. Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging 2007;34:1699-700.
5. Flower MA, McReady VR. Radionuclide therapy dose calculations: what accuracy can be achieved? Eur J Nucl Med 1997;24:1462-4.
6. Chiesa C, Albertini F, Castellani MR, Aprigliano G, Bombardieri E. Dosimetry during 131I-mIBG therapy in neuroblastoma pediatric patients. Proceedings of the 7th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging (AIMN). Q J Nucl Med Mol Imaging 2004;48(Suppl 1-3):72-3.
7. Canzi C, Zito F, Voltini F, Reschini E, Gerundini P. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. Med Phys 2006;33:2860-7.
8. Koral K, Hiberty J, Frame B, Matthay K, Maris J, Reagan D et al. Hepatic radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma. Eur J Nucl Med Mol Imaging 2008;35:2105-22.
9. Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJR, Coakley AJ. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med 1966;23:123-30.
10. National Council on Radiation Protection and Measurement. Sources and magnitude of occupational and public exposures from nuclear medicine procedures - 1996 NCRP report n. 124.
11. Chiesa C, De Sanctis V, Crippa F, Schiavini M, Fraigola CE, Bogni A et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxiglucose. Eur J Nucl Med 1997;24:1380-9.
12. Pollard KR, Bice AN, Eary JF, Duraci LD, Lewellen TK. A method for imaging therapeutic doses of iodine-131 with a clinical gammacamera. J Nucl Med 1992;33:771-6.
13. Freedman GS, Kinsela T, Dwyer A. A correction method for high count rate quantitative radionuclide angiography. Radiology 1972;104:713-75.
14. Sorenson JA. Methods for correcting Anger camera dead time losses. J Nucl Med 1976;17:137-41.
15. Inoue Y, M Omose T, Ohtake T, Asai S, Yoshikawa K, Nishikawa J, Sasaki Y. Effect of dead time loss on quantitative measurement of cerebral blood flow with technecium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1997;24:1418-21.
16. Delpon G, Ferrer L, Lisbona A, Bardies M. Correction of count losses due to deadtime on a DST-XLi (SMVi-GE) camera during dosimetric studies in patients injected with iodine-131- Phys Med Biol 2002;47:N79-N90.
17. Woldeselassie T. Precise real-time correction of anger camera dead time losses. Med Phys 2002;29:1599-10.
18. Sorenson JA. Dead time characteristics of Anger cameras. J Nucl Med 1975;16.